168 related articles for article (PubMed ID: 34837139)
1. Nationwide mammographic screening and breast cancer mortality in Taiwan: an interrupted time-series analysis.
Su SY
Breast Cancer; 2022 Mar; 29(2):336-342. PubMed ID: 34837139
[TBL] [Abstract][Full Text] [Related]
2. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years.
Bailey SL; Sigal BM; Plevritis SK
J Natl Cancer Inst; 2010 Aug; 102(16):1263-71. PubMed ID: 20664027
[TBL] [Abstract][Full Text] [Related]
3. Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004-2020.
Yao MM; Vy VPT; Chen TH; Hsu HH; Hsu GC; Lee CS; Lin LJ; Chia SL; Wu CC; Chan WP; Yen AM
BMC Med; 2023 Dec; 21(1):497. PubMed ID: 38102671
[TBL] [Abstract][Full Text] [Related]
4. The outcome of a quality-controlled mammography screening program: experience from a population-based study in Taiwan.
Pan HB; Wong KF; Yang TL; Hsu GC; Chou CP; Huang JS; Lee SK; Chou YH; Chiang CL; Liang HL
J Chin Med Assoc; 2014 Oct; 77(10):531-4. PubMed ID: 25103986
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study.
Mukhtar TK; Yeates DR; Goldacre MJ
J R Soc Med; 2013 Jun; 106(6):234-42. PubMed ID: 23761583
[TBL] [Abstract][Full Text] [Related]
6. The relative effect of mammographic screening on breast cancer mortality by socioeconomic status.
Ripping TM; van der Waal D; Verbeek ALM; Broeders MJM
Medicine (Baltimore); 2016 Aug; 95(31):e4335. PubMed ID: 27495038
[TBL] [Abstract][Full Text] [Related]
7. Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening.
Moorman SEH; Pujara AC; Sakala MD; Neal CH; Maturen KE; Swartz L; Egloff H; Helvie MA
AJR Am J Roentgenol; 2021 Jul; 217(1):40-47. PubMed ID: 33955776
[No Abstract] [Full Text] [Related]
8. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer screening by mammography in women aged under 50 years in Japan.
Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
[TBL] [Abstract][Full Text] [Related]
10. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
May DS; Lee NC; Nadel MR; Henson RM; Miller DS
AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
[TBL] [Abstract][Full Text] [Related]
11. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.
Hauge IH; Pedersen K; Olerud HM; Hole EO; Hofvind S
Acta Radiol; 2014 Dec; 55(10):1174-9. PubMed ID: 24311702
[TBL] [Abstract][Full Text] [Related]
12. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
Hendrick RE
Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
[TBL] [Abstract][Full Text] [Related]
13. Mammographic density in birth cohorts of Danish women: a longitudinal study.
Hellmann SS; Lynge E; Schwartz W; Vejborg I; Njor SH
BMC Cancer; 2013 Sep; 13():409. PubMed ID: 24106754
[TBL] [Abstract][Full Text] [Related]
14. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits.
Berrington de González A; Reeves G
Br J Cancer; 2005 Sep; 93(5):590-6. PubMed ID: 16136033
[TBL] [Abstract][Full Text] [Related]
15. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.
Morrell S; Taylor R; Roder D; Dobson A
J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322
[TBL] [Abstract][Full Text] [Related]
16. Outcome of mammography examination in asymptomatic women.
Kolade-Yunusa HO; Itanyi UD
Ann Afr Med; 2021; 20(1):52-58. PubMed ID: 33727513
[TBL] [Abstract][Full Text] [Related]
17. Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination: A Propensity Score Analysis of 1 429 890 Taiwanese Women.
Yen AM; Tsau HS; Fann JC; Chen SL; Chiu SY; Lee YC; Pan SL; Chiu HM; Kuo WH; Chang KJ; Wu YY; Chuang SL; Hsu CY; Chang DC; Koong SL; Wu CY; Chia SL; Chen MJ; Chen HH; Chiou ST
JAMA Oncol; 2016 Jul; 2(7):915-21. PubMed ID: 27030951
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.
Monticciolo DL; Newell MS; Hendrick RE; Helvie MA; Moy L; Monsees B; Kopans DB; Eby PR; Sickles EA
J Am Coll Radiol; 2017 Sep; 14(9):1137-1143. PubMed ID: 28648873
[TBL] [Abstract][Full Text] [Related]
19. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
20. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
Mango VL; Goel A; Mema E; Kwak E; Ha R
J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
